Split-scene illustration of UCSF mouse study: older mouse struggles in maze with poor hippocampal neural links due to FTL1; treated mouse excels with enhanced connections.
Split-scene illustration of UCSF mouse study: older mouse struggles in maze with poor hippocampal neural links due to FTL1; treated mouse excels with enhanced connections.
AI द्वारा उत्पन्न छवि

UCSF study links iron-associated protein FTL1 to age-related memory decline in mice

AI द्वारा उत्पन्न छवि
तथ्य-जाँच किया गया

Researchers at the University of California, San Francisco report that higher levels of the iron-associated protein FTL1 in the hippocampus of older mice are tied to weaker neural connections and worse performance on cognitive tests. In the experiments, reducing FTL1 in older mice was associated with increased neuronal connectivity and improved memory performance, findings published in Nature Aging.

Scientists at the University of California, San Francisco tracked changes in genes and proteins in the hippocampus of mice as they aged and identified FTL1 as the protein that most consistently differed between young and old animals, according to a research summary released by the university.

In older mice, the researchers reported higher levels of FTL1 alongside fewer connections between neurons in the hippocampus and poorer performance on cognitive tests. In a separate set of experiments, boosting FTL1 in young mice caused the animals’ brains and behavior to resemble those of older mice. In lab experiments, neurons engineered to produce high amounts of FTL1 developed simplified structures, forming shorter, less complex extensions.

The team also reported a metabolic link: higher FTL1 levels in older mice were associated with slower cellular metabolism in the hippocampus. When researchers treated cells with a compound described as boosting metabolism, they found the negative effects were prevented.

The most dramatic effects were reported when FTL1 was reduced in older mice. The researchers said connections between brain cells increased and performance on memory tests improved.

“It is truly a reversal of impairments,” said Saul Villeda, PhD, associate director of the UCSF Bakar Aging Research Institute and senior author of the paper. “It’s much more than merely delaying or preventing symptoms.”

Villeda said the work could point to future approaches aimed at countering age-related brain decline. “We’re seeing more opportunities to alleviate the worst consequences of old age,” he said. “It’s a hopeful time to be working on the biology of aging.”

The paper is titled “Targeting iron-associated protein Ftl1 in the brain of old mice improves age-related cognitive impairment,” and was published in Nature Aging. The university said the work was funded in part by the Simons Foundation, the Bakar Family Foundation, the National Science Foundation, the Hillblom Foundation, the Bakar Aging Research Institute, Marc and Lynne Benioff, and the National Institutes of Health.

लोग क्या कह रहे हैं

Early discussions on X about the UCSF study express optimism regarding the reversal of age-related memory decline in mice by reducing FTL1 protein levels, with users summarizing the findings on improved neural connectivity and cognitive performance. Some highlight therapeutic potential for human aging, while others note the need for caution on applicability to humans. Reactions are mostly neutral to positive from science enthusiasts and regular users.

संबंधित लेख

Scientists at Virginia Tech using CRISPR tools to improve memory in aged rats, illustrating potential for combating cognitive decline.
AI द्वारा उत्पन्न छवि

Virginia Tech team improves memory in aged rats with targeted gene-editing

AI द्वारा रिपोर्ट किया गया AI द्वारा उत्पन्न छवि तथ्य-जाँच किया गया

Scientists at Virginia Tech report that tuning specific molecular pathways with CRISPR-based tools improved memory in older rats across two peer‑reviewed studies, pointing to possible routes for tackling age‑related cognitive decline.

Researchers at the University of California, San Francisco, have discovered a mechanism by which exercise helps protect the brain from age-related damage associated with Alzheimer's disease. Physical activity prompts the liver to release an enzyme that repairs the blood-brain barrier, reducing inflammation and improving memory in older mice. The findings, published in the journal Cell, highlight a body-to-brain pathway that could lead to new therapies.

AI द्वारा रिपोर्ट किया गया

New research reveals that blood from younger mice can protect against Alzheimer's-like brain damage, while older blood accelerates it. Scientists conducted experiments infusing mouse blood over 30 weeks to observe effects on memory and protein buildup. The findings highlight blood's role in brain health and potential new treatments.

Washington University scientists report that inhibiting the circadian regulator REV-ERBα raised brain NAD+ and reduced tau pathology in mouse models, pointing to a clock-focused strategy worth exploring for Alzheimer’s disease.

AI द्वारा रिपोर्ट किया गया

A new study links temporal lobe epilepsy to early aging in brain support cells, showing that clearing these cells in mice reduces seizures and improves memory. Researchers at Georgetown University Medical Center used existing drugs to achieve these results, offering potential for faster treatments in humans. The findings, published on December 22, highlight hope for patients resistant to current medications.

Researchers report that tanycytes—specialized cells lining the brain’s third ventricle—can help move tau protein from cerebrospinal fluid into the bloodstream, and that signs of tanycyte disruption in Alzheimer’s patient tissue may be associated with impaired tau removal. The findings, published March 5 in Cell Press Blue, are based on animal and cell experiments and analyses of human brain samples.

AI द्वारा रिपोर्ट किया गया तथ्य-जाँच किया गया

Researchers at NYU Langone Health report that inhibiting the protein FSP1 induces ferroptosis and markedly slows lung adenocarcinoma in mouse models. The study, published online in Nature on November 5, 2025, found tumor growth reductions of up to 80% in preclinical tests, according to the institution.

 

 

 

यह वेबसाइट कुकीज़ का उपयोग करती है

हम अपनी साइट को बेहतर बनाने के लिए विश्लेषण के लिए कुकीज़ का उपयोग करते हैं। अधिक जानकारी के लिए हमारी गोपनीयता नीति पढ़ें।
अस्वीकार करें